MicroRNAs regulate several functions of normal tissues and malignancies

Taiwanese Journal of Obstetrics and Gynecology

Volumn 52, Issue 4, 2013, Pages 465-469

  Wen, Kuo Chang ^a,b   Sung, Pi Ling ^a,b   Yen, Ming Shyen ^a,b   Chuang, Chi Mu ^a,b   Liou, Wen Shiung ^c   Wang, Peng Hui ^a,b,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cancer stem cell; MicroRNA; Ovarian cancer

Indexed keywords

MICRORNA; MICRORNA 21;

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL FUNCTION; DISEASE COURSE; HUMAN; NEOPLASM; NONHUMAN; OVARY CANCER; REGULATORY MECHANISM; REVIEW; TISSUES;

CANCER STEM CELL; MICRORNA; OVARIAN CANCER;

CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS;

EID: 84892369187     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2013.10.002     Document Type: Review

References (41)

1. Balch C., Matei D.E., Huang T.H., Nephew K.P. Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2010, 2:419-447.
2. Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., Calin G.A. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011, 8:467-477.
3. Di Leva G., Croce C.M. The role of microRNAs in the tumorigenesis of ovarian cancer. Front Oncol 2013, 3:153.
4. Põlajeva J., Swartling F.J., Jiang Y., Singh U., Pietras K., Uhrbom L., et al. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma. BMC Cancer 2012, 12:378.
5. Mraz M., Pospisilova S. MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev Hematol 2012, 5:579-581.
6. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529.
7. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
8. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
9. Møller H.G., Rasmussen A.P., Andersen H.H., Johnsen K.B., Henriksen M., Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol 2013, 47:131-144.
10. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852.
11. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007, 17:1298-1307.
12. Olivieri F., Rippo M.R., Monsurrò V., Salvioli S., Capri M., Procopio A.D., et al. MicroRNAs linking inflamm-aging, cellular senescence and cancer. Ageing Res Rev 2013, [accessed 29.10.13]. 10.1016/j.arr.2013.05.001.
13. Lou Y., Cui Z., Wang F., Yang X., Qian J. miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells. Clin Invest Med 2011, 34:E281.
14. Nam E.J., Yoon H., Kim S.W., Kim H., Kim Y.T., Kim J.H., et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008, 14:2690-2695.
15. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
16. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. Cancer Genome Atlas Research Network.
17. Chao K.C., Chen Y.J., Juang C.M., Lau H.Y., Wen K.C., Sung P.L., et al. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan. Taiwan J Obstet Gynecol 2013, 52:81-84.
18. Shih C.Y., Lai C.R., Huang C.Y., Twu N.F., Chao K.C., Wang P.H. A challenge in the management of a patient with ovarian cancer associated with extensive endometriosis. Taiwan J Obstet Gynecol 2012, 51:324-325.
19. Yang D., Sun Y., Hu L., Zheng H., Ji P., Pecot C.V., et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 2013, 23:186-199.
20. Balch C., Nephew K.P. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer. Cancer Biomark 2010-2011, 8:203-221.
21. Curley M.D., Therrien V.A., Cummings C.L., Sergent P.A., Koulouris C.R., Friel A.M., et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009, 27:2875-2883.
22. Skubitz A.P., Taras E.P., Boylan K.L., Waldron N.N., Oh S., Panoskaltsis-Mortari A., et al. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression. Gynecol Oncol 2013, 130:579-587.
23. Zhao L., Chen X., Cao Y. New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai) 2011, 43:831-839.
24. Liu C., Tang D.G. MicroRNA regulation of cancer stem cells. Cancer Res 2011, 71:5950-5954.
25. Han M., Liu M., Wang Y., Mo Z., Bi X., Liu Z., et al. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Mol Cell Biochem 2012, 363:427-436.
26. Han M., Wang Y., Liu M., Bi X., Bao J., Zeng N., et al. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells. Cancer Sci 2012, 103:1058-1064.
27. Zhou L., Yang Z.X., Song W.J., Li Q.J., Yang F., Wang D.S., et al. MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int J Oncol 2013, 43:661-669.
28. Zhang S., Wan Y., Pan T., Gu X., Qian C., Sun G., et al. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. J Mol Neurosci 2012, 47:346-356.
29. + spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. BMC Med Genomics 2012, 5:18.
30. Chung W.M., Chang W.C., Chen L., Chang Y.Y., Shyr C.R., Hung Y.C., et al. MicroRNA-21 promotes ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progeny populations in vitro. Stem Cell Res Ther 2013, 26:4.
31. Zhang L., Volinia S., Bonome T., Calin G.A., Greshock J., Yang N., et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008, 105:7004-7009.
32. Bhattacharya R., Nicoloso M., Arvizo R., Wang E., Cortez A., Rossi S., et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009, 69:9090-9095.
33. Lee C.H., Subramanian S., Beck A.H., Espinosa I., Senz J., Zhu S.X., et al. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS ONE 2009, 4:e7314.
34. Dahiya N., Sherman-Baust C.A., Wang T.L., Davidson B., Shih IeM., Zhang Y., et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008, 3:e2436.
35. Yeh Y.M., Chuang C.M., Chao K.C., Wang L.H. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer 2013, 133:867-878.
36. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
37. Chao A., Lin C.Y., Lee Y.S., Tsai C.L., Wei P.C., Hsueh S., et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Oncogene 2012, 31:764-775.
38. Wyman S.K., Parkin R.K., Mitchell P.S., Fritz B.R., O'Briant K., Godwin A.K., et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 2009, 4:e5311.
39. Sorrentino A., Liu C.G., Addario A., Peschle C., Scambia G., Ferlini C. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008, 111:478-486.
40. Lee W.L., Lee F.K., Su W.H., Tsui K.H., Kuo C.D., Hsieh S.L., et al. Hormone therapy for younger patients with endometrial cancer. Taiwan J Obstet Gynecol 2012, 51:495-505.
41. Su W.H., Ho T.Y., Li Y.T., Lu C.H., Lee W.L., Wang P.H. Metronomic therapy for gynecologic cancers. Taiwan J Obstet Gynecol 2012, 51:167-178.